231 related articles for article (PubMed ID: 38096051)
41. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
[TBL] [Abstract][Full Text] [Related]
42. L1 retrotransposition in neurons is modulated by MeCP2.
Muotri AR; Marchetto MC; Coufal NG; Oefner R; Yeo G; Nakashima K; Gage FH
Nature; 2010 Nov; 468(7322):443-6. PubMed ID: 21085180
[TBL] [Abstract][Full Text] [Related]
43. Deleting
Achilly NP; He LJ; Kim OA; Ohmae S; Wojaczynski GJ; Lin T; Sillitoe RV; Medina JF; Zoghbi HY
Elife; 2021 Jan; 10():. PubMed ID: 33494858
[TBL] [Abstract][Full Text] [Related]
44. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
Bissonnette JM; Knopp SJ
Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
[TBL] [Abstract][Full Text] [Related]
45. EEA1 restores homeostatic synaptic plasticity in hippocampal neurons from Rett syndrome mice.
Xu X; Pozzo-Miller L
J Physiol; 2017 Aug; 595(16):5699-5712. PubMed ID: 28621434
[TBL] [Abstract][Full Text] [Related]
46. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
[TBL] [Abstract][Full Text] [Related]
47. An optogenetic mouse model of rett syndrome targeting on catecholaminergic neurons.
Zhang S; Johnson CM; Cui N; Xing H; Zhong W; Wu Y; Jiang C
J Neurosci Res; 2016 Oct; 94(10):896-906. PubMed ID: 27317352
[TBL] [Abstract][Full Text] [Related]
48. Gene length matters in neurons.
Zylka MJ; Simon JM; Philpot BD
Neuron; 2015 Apr; 86(2):353-5. PubMed ID: 25905808
[TBL] [Abstract][Full Text] [Related]
49. Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state.
Tiwari VK; Burger L; Nikoletopoulou V; Deogracias R; Thakurela S; Wirbelauer C; Kaut J; Terranova R; Hoerner L; Mielke C; Boege F; Murr R; Peters AH; Barde YA; Schübeler D
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):E934-43. PubMed ID: 22474351
[TBL] [Abstract][Full Text] [Related]
50. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
51. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
52. MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain.
Nguyen MV; Du F; Felice CA; Shan X; Nigam A; Mandel G; Robinson JK; Ballas N
J Neurosci; 2012 Jul; 32(29):10021-34. PubMed ID: 22815516
[TBL] [Abstract][Full Text] [Related]
53. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
Martínez de Paz A; Ausió J
Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
[TBL] [Abstract][Full Text] [Related]
54. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
55. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
56. Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus.
Ben-Shachar S; Chahrour M; Thaller C; Shaw CA; Zoghbi HY
Hum Mol Genet; 2009 Jul; 18(13):2431-42. PubMed ID: 19369296
[TBL] [Abstract][Full Text] [Related]
57. Mutations in the transcriptional regulator MeCP2 severely impact key cellular and molecular signatures of human astrocytes during maturation.
Sun J; Osenberg S; Irwin A; Ma LH; Lee N; Xiang Y; Li F; Wan YW; Park IH; Maletic-Savatic M; Ballas N
Cell Rep; 2023 Jan; 42(1):111942. PubMed ID: 36640327
[TBL] [Abstract][Full Text] [Related]
58. Deciphering Rett syndrome with mouse genetics, epigenomics, and human neurons.
Tao J; Wu H; Sun YE
Int Rev Neurobiol; 2009; 89():147-60. PubMed ID: 19900619
[TBL] [Abstract][Full Text] [Related]
59. piRNAs warrant investigation in Rett Syndrome: an omics perspective.
Saxena A; Tang D; Carninci P
Dis Markers; 2012; 33(5):261-75. PubMed ID: 22976001
[TBL] [Abstract][Full Text] [Related]
60. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
